|
|
Article: American Heart Association Journal, Circulation, Publishes New Peer-Reviewed Study Involving Protandim(R).
- Article from:
- PR Newswire
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Study Concludes that Protandim Preserved Heart Function and Demonstrated Strong Cardioprotective Effects in an Animal Model of Lung Disease Osteopontin levels reduced by more than 50%; heart output preserved and cardiac fibrosis prevented in animals
SAN DIEGO, Nov. 3 /PRNewswire-FirstCall/ -- LifeVantage Corporation (OTC Bulletin Board: LFVN), announced that in a peer-reviewed manuscript published in the prestigious American Heart Association journal Circulation, Dr. Norbert Voelkel and researchers at Virginia Commonwealth University (VCU), demonstrated the ability of Protandim, the Company's patented dietary supplement composed of five highly synergistic ...